Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease

被引:28
|
作者
Zhou-wen CHEN
机构
关键词
Nonalcoholic fatty liver disease (NAFLD); Alanine aminotransferase (ALT); Metabolic syndrome (MS);
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
Objective:To investigate the relationship between alanine aminotransferase (ALT) levels and metabolic syndrome (MS) in nonalcoholic fatty liver disease (NAFLD). Methods: A total of 26527 subjects who received medical health checkup in our hospital from January 2005 to July 2007 were enrolled in the study. The diagnosis of fatty liver was based on ultrasound imaging. MS was defined according to the criteria of the Adult Treatment Panel III. ALT, triglyceride (TG), high density lipo-protein cholesterol (HDL-c), fasting plasma glucose (FPG), height, weight, waist circumference (WC), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in each subject to analyze the relationship between MS and ALT activity. Results: (1) The prevalence of NAFLD in men (30.94%) was significantly higher than that in women (15.65%); (2) The incidence of MS in NAFLD (33.83%) was significantly greater than that in non-NAFLD (10.62%); (3) Of the 6470 subjects with NAFLD, in the age-adjusted partial correlation analysis, there were statistically significant correlations between the ALT levels and most metabolic risk factors in each sex (P<0.01), except that ALT levels had no correlation with HDL-c in women. Moreover, in the multiple stepwise regression analysis, SBP lost its significance, and WC, body mass index (BMI), age, DBP, TG and FPG were independently associated with ALT levels in both sexes (P<0.05). HDL-c remained significant and was independently related to ALT levels in men; (4) ALT levels were significantly higher in subjects with MS compared to those without MS (P<0.001). Mean ALT levels increased with the number of MS components in each sex (P<0.05 for trend). Conclusion: We found a strong rela-tionship between ALT levels and MS in NAFLD and revealed that the cluster of MS components might be the predictor for ALT elevations.
引用
收藏
页码:616 / 622
页数:7
相关论文
共 50 条
  • [1] Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease
    Chen, Zhou-wen
    Chen, Li-ying
    Dai, Hong-lei
    Chen, Jian-hua
    Fang, Li-zheng
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2008, 9 (08): : 616 - 622
  • [2] Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease
    Zhou-wen Chen
    Li-ying Chen
    Hong-lei Dai
    Jian-hua Chen
    Li-zheng Fang
    Journal of Zhejiang University SCIENCE B, 2008, 9
  • [3] A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease
    Yamada-Shimizu, Michiko
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Ishido, Shun
    Nobusawa, Tsubasa
    Matsumoto, Hiroaki
    Keitoku, Taisei
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    INTERNAL MEDICINE, 2024, 63 (09) : 1185 - 1190
  • [4] Nonalcoholic Fatty Liver Disease in Children and Adolescents - Relationship with Polycystic Ovary Syndrome
    Adriana Abruzzese, Giselle
    Beatriz Motta, Alicia
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (35) : 5144 - 5150
  • [5] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [6] The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease
    Sheng, Xia
    Che, Hui
    Ji, Qingming
    Yang, Fan
    Lv, Jie
    Wang, Yueqiu
    Xian, Huimin
    Wang, Lihong
    HORMONE AND METABOLIC RESEARCH, 2018, 50 (05) : 397 - 402
  • [7] Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations
    Kovalic, Alexander J.
    Cholankeril, George
    Satapathy, Sanjaya K.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [8] Nonalcoholic Fatty Liver Disease
    Sweet, Patrick H.
    Khoo, Teresa
    Nguyen, Steven
    PRIMARY CARE, 2017, 44 (04): : 599 - +
  • [9] Nonalcoholic Fatty Liver Disease
    Paredes, Angelo H.
    Torres, Dawn M.
    Harrison, Stephen A.
    CLINICS IN LIVER DISEASE, 2012, 16 (02) : 397 - +
  • [10] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173